TempraMed reports record July sales and strong August performance
TempraMed says July sales were US$522K and August sales were US$403K. It also reports first-eight-month 2026 sales of US$2.07M, exceeding total 2025 sales of US$1.8M.
8M in total sales for 2025Toronto, Ontario--(. - September 18, 2026) - TempraMed Technologies Ltd. CSE:VIVI (FSE: 9DY) (OTCQB: TMPTF) ("TempraMed" o…